Free Newsletter
Clinical trial materials maker expands
Velesco Pharmaceutical Services, formed in 2007 by former Pfizer R&D colleagues in Michigan, has opened a manufacturing facility and office in Kalamazoo and moved its Ann Arbor labs to the Michigan Life Science and Innovation Center in Plymouth. The move provides space to accommodate the growth of its analytical and drug formulation lab services, the company says.
Velesco supports the early-stage work of drug makers by providing analytical method development, drug formulation, stability testing and consulting services.
The 10,000-square-foot office and manufacturing facility will be used to make non-sterile cGMP clinical trial supplies. Product offerings will include powder-in-capsule, powder-in-bottle, ointments/creams, oral and topical liquids, over-encapsulation for blinded studies and packaging, according to an announcement.
- read the announcement
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: